Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal effects of continuing tenofovir versus switching to abacavir in HIV-positive persons
2006-006174-19Phase 4Completed
- Sponsor
- St Stephen's AIDS Trust
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tenofovir disoproxil fumarate and abacavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by St Stephen's AIDS Trust. Primary endpoint: Glomerular filtration rate (GFR) by MDRD calculation. Started Nov 2006; status: completed.
02
Drugs
tenofovir disoproxil fumarateabacavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006174-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006174-19.